Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Infective Endocarditis Outcomes in Japan: A Nationwide

Takahiro Kuno1, Yoshiaki Ohyama1,2, Yoko Sumita3

  • 1Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine Gunma Japan.

Circulation Reports
|April 13, 2026
PubMed

Insights

The COVID-19 pandemic did not significantly alter in-hospital mortality for infective endocarditis (IE) patients in Japan after risk adjustment. While unadjusted mortality was higher post-pandemic, valve surgery rates remained stable, though stroke incidence increased.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Infective endocarditis (IE) poses a significant mortality risk.
  • The COVID-19 pandemic has impacted healthcare systems globally.
  • The effect of the pandemic on IE outcomes in Japan is not well understood.

Purpose of the Study:

  • To assess the impact of the COVID-19 pandemic on in-hospital mortality for IE patients in Japan.
  • To evaluate changes in valve surgery rates among IE patients during the pandemic.
  • To analyze the association between the pandemic and IE patient outcomes in Japan.

Main Methods:

  • Retrospective analysis of the Japanese registry of all Cardiac and Vascular Diseases Diagnostic Procedure Combination (JROAD-DPC) database.
  • Inclusion of 19,077 adult patients hospitalized with IE from April 2016 to March 2022.
  • 1:1 propensity score matching to compare pre-COVID-19 and post-COVID-19 periods (6,652 pairs).

Main Results:

  • Unadjusted in-hospital mortality was higher in the post-COVID-19 period (15.7% vs. 13.9%, P<0.001).
  • Risk-adjusted in-hospital mortality showed no significant difference between periods (15.7% vs. 15.3%, P=0.60).
  • Valve surgery rates (26.4% vs. 25.5%, P=0.22) and stroke incidence (8.3% vs. 7.3%, P=0.049) were analyzed.

Conclusions:

  • Risk-adjusted in-hospital mortality for infective endocarditis was not significantly different during the COVID-19 pandemic in Japan.
  • Unadjusted mortality was higher in the post-pandemic period, suggesting confounding factors.
  • The study highlights the importance of risk adjustment in evaluating pandemic-related healthcare impacts.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
855
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
347
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
828
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
600
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
327
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K